The Value of Telemedicine for the Follow-up of Patients with New Onset Type 1 Diabetes Mellitus During COVID-19 Pandemic in Turkey: A Report of Eight Cases
The current Coronavirus disease-2019 (COVID-19) pandemic has forced health care teams to look for alternative approaches to manage a great number of children with diabetes, not only in rural but also in urban locations. The aim was to assess the provision of information about follow-up of new-onset...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Galenos Yayincilik
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8ea6db80154848dd937262e2e7ba4643 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:8ea6db80154848dd937262e2e7ba4643 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:8ea6db80154848dd937262e2e7ba46432021-11-26T06:10:17ZThe Value of Telemedicine for the Follow-up of Patients with New Onset Type 1 Diabetes Mellitus During COVID-19 Pandemic in Turkey: A Report of Eight Cases1308-57271308-573510.4274/jcrpe.galenos.2020.2020.0160https://doaj.org/article/8ea6db80154848dd937262e2e7ba46432021-12-01T00:00:00Z http://www.jcrpe.org/archives/archive-detail/article-preview/the-value-of-telemedicine-for-the-follow-up-of-pat/41648 https://doaj.org/toc/1308-5727https://doaj.org/toc/1308-5735The current Coronavirus disease-2019 (COVID-19) pandemic has forced health care teams to look for alternative approaches to manage a great number of children with diabetes, not only in rural but also in urban locations. The aim was to assess the provision of information about follow-up of new-onset pediatric type 1 diabetes (T1D) patients, and to investigate the integration of telemedicine into routine clinical care in the long term. The changes in coefficient of variation (CV), standard deviation and percentages of time in range (TIR), time below range (TBR) and time above range were evaluated in eight children with new-onset T1D, diagnosed during the COVID-19 pandemic. The study period was two-months of follow-up using a telemedicine system. Median follow-up time was 51 (24-66) days. Two of the patients were using low glucose suspend system and six were on multiple daily injection therapy. Target TIR values were achieved in seven patients in the last televisit and, in line with recent guidelines, a TBR <70 mg/dL (<3.9 mmol/L) (level 1 hypoglycemia) of <4% and a TBR <54 mg/dL (<3.0 mmol/L) (level 2 hypoglycemia) of <1% were achieved in all patients. Seven patients achieved a CV of <36% at their last televisit. Telemedicine as an alternative follow-up tool during unusual circumstances such pandemics, even in countries where it is not routinely used, could be beneficial to achieve optimum glycemic control in patients with new-onset T1D.Ferda EvinEren ErAysun AtaArzu JalilovaGünay DemirYasemin Atik AltınokSamim ÖzenŞükran DarcanDamla GökşenGalenos Yayincilikarticletype 1 diabetestelemedicinecovid-19technologysensor augmented pumpPediatricsRJ1-570Diseases of the endocrine glands. Clinical endocrinologyRC648-665ENJCRPE, Vol 13, Iss 4, Pp 468-472 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
type 1 diabetes telemedicine covid-19 technology sensor augmented pump Pediatrics RJ1-570 Diseases of the endocrine glands. Clinical endocrinology RC648-665 |
spellingShingle |
type 1 diabetes telemedicine covid-19 technology sensor augmented pump Pediatrics RJ1-570 Diseases of the endocrine glands. Clinical endocrinology RC648-665 Ferda Evin Eren Er Aysun Ata Arzu Jalilova Günay Demir Yasemin Atik Altınok Samim Özen Şükran Darcan Damla Gökşen The Value of Telemedicine for the Follow-up of Patients with New Onset Type 1 Diabetes Mellitus During COVID-19 Pandemic in Turkey: A Report of Eight Cases |
description |
The current Coronavirus disease-2019 (COVID-19) pandemic has forced health care teams to look for alternative approaches to manage a great number of children with diabetes, not only in rural but also in urban locations. The aim was to assess the provision of information about follow-up of new-onset pediatric type 1 diabetes (T1D) patients, and to investigate the integration of telemedicine into routine clinical care in the long term. The changes in coefficient of variation (CV), standard deviation and percentages of time in range (TIR), time below range (TBR) and time above range were evaluated in eight children with new-onset T1D, diagnosed during the COVID-19 pandemic. The study period was two-months of follow-up using a telemedicine system. Median follow-up time was 51 (24-66) days. Two of the patients were using low glucose suspend system and six were on multiple daily injection therapy. Target TIR values were achieved in seven patients in the last televisit and, in line with recent guidelines, a TBR <70 mg/dL (<3.9 mmol/L) (level 1 hypoglycemia) of <4% and a TBR <54 mg/dL (<3.0 mmol/L) (level 2 hypoglycemia) of <1% were achieved in all patients. Seven patients achieved a CV of <36% at their last televisit. Telemedicine as an alternative follow-up tool during unusual circumstances such pandemics, even in countries where it is not routinely used, could be beneficial to achieve optimum glycemic control in patients with new-onset T1D. |
format |
article |
author |
Ferda Evin Eren Er Aysun Ata Arzu Jalilova Günay Demir Yasemin Atik Altınok Samim Özen Şükran Darcan Damla Gökşen |
author_facet |
Ferda Evin Eren Er Aysun Ata Arzu Jalilova Günay Demir Yasemin Atik Altınok Samim Özen Şükran Darcan Damla Gökşen |
author_sort |
Ferda Evin |
title |
The Value of Telemedicine for the Follow-up of Patients with New Onset Type 1 Diabetes Mellitus During COVID-19 Pandemic in Turkey: A Report of Eight Cases |
title_short |
The Value of Telemedicine for the Follow-up of Patients with New Onset Type 1 Diabetes Mellitus During COVID-19 Pandemic in Turkey: A Report of Eight Cases |
title_full |
The Value of Telemedicine for the Follow-up of Patients with New Onset Type 1 Diabetes Mellitus During COVID-19 Pandemic in Turkey: A Report of Eight Cases |
title_fullStr |
The Value of Telemedicine for the Follow-up of Patients with New Onset Type 1 Diabetes Mellitus During COVID-19 Pandemic in Turkey: A Report of Eight Cases |
title_full_unstemmed |
The Value of Telemedicine for the Follow-up of Patients with New Onset Type 1 Diabetes Mellitus During COVID-19 Pandemic in Turkey: A Report of Eight Cases |
title_sort |
value of telemedicine for the follow-up of patients with new onset type 1 diabetes mellitus during covid-19 pandemic in turkey: a report of eight cases |
publisher |
Galenos Yayincilik |
publishDate |
2021 |
url |
https://doaj.org/article/8ea6db80154848dd937262e2e7ba4643 |
work_keys_str_mv |
AT ferdaevin thevalueoftelemedicineforthefollowupofpatientswithnewonsettype1diabetesmellitusduringcovid19pandemicinturkeyareportofeightcases AT erener thevalueoftelemedicineforthefollowupofpatientswithnewonsettype1diabetesmellitusduringcovid19pandemicinturkeyareportofeightcases AT aysunata thevalueoftelemedicineforthefollowupofpatientswithnewonsettype1diabetesmellitusduringcovid19pandemicinturkeyareportofeightcases AT arzujalilova thevalueoftelemedicineforthefollowupofpatientswithnewonsettype1diabetesmellitusduringcovid19pandemicinturkeyareportofeightcases AT gunaydemir thevalueoftelemedicineforthefollowupofpatientswithnewonsettype1diabetesmellitusduringcovid19pandemicinturkeyareportofeightcases AT yaseminatikaltınok thevalueoftelemedicineforthefollowupofpatientswithnewonsettype1diabetesmellitusduringcovid19pandemicinturkeyareportofeightcases AT samimozen thevalueoftelemedicineforthefollowupofpatientswithnewonsettype1diabetesmellitusduringcovid19pandemicinturkeyareportofeightcases AT sukrandarcan thevalueoftelemedicineforthefollowupofpatientswithnewonsettype1diabetesmellitusduringcovid19pandemicinturkeyareportofeightcases AT damlagoksen thevalueoftelemedicineforthefollowupofpatientswithnewonsettype1diabetesmellitusduringcovid19pandemicinturkeyareportofeightcases AT ferdaevin valueoftelemedicineforthefollowupofpatientswithnewonsettype1diabetesmellitusduringcovid19pandemicinturkeyareportofeightcases AT erener valueoftelemedicineforthefollowupofpatientswithnewonsettype1diabetesmellitusduringcovid19pandemicinturkeyareportofeightcases AT aysunata valueoftelemedicineforthefollowupofpatientswithnewonsettype1diabetesmellitusduringcovid19pandemicinturkeyareportofeightcases AT arzujalilova valueoftelemedicineforthefollowupofpatientswithnewonsettype1diabetesmellitusduringcovid19pandemicinturkeyareportofeightcases AT gunaydemir valueoftelemedicineforthefollowupofpatientswithnewonsettype1diabetesmellitusduringcovid19pandemicinturkeyareportofeightcases AT yaseminatikaltınok valueoftelemedicineforthefollowupofpatientswithnewonsettype1diabetesmellitusduringcovid19pandemicinturkeyareportofeightcases AT samimozen valueoftelemedicineforthefollowupofpatientswithnewonsettype1diabetesmellitusduringcovid19pandemicinturkeyareportofeightcases AT sukrandarcan valueoftelemedicineforthefollowupofpatientswithnewonsettype1diabetesmellitusduringcovid19pandemicinturkeyareportofeightcases AT damlagoksen valueoftelemedicineforthefollowupofpatientswithnewonsettype1diabetesmellitusduringcovid19pandemicinturkeyareportofeightcases |
_version_ |
1718409792566853632 |